Aethlon Medical Inc (AEMD)

[cazual]

AEMD $$$$ Aethlon Medical, Inc. (OTCMKTS:AEMD) Successfully Beating Ebola

.....AEMD currently averages just under $500,000 a quarter in revenues that are derived from a DARPA Government contract that was awarded to the Company back in September 2011. Under the terms of the contract Aethlon is developing a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection that often results in the death of combat-injured soldiers. The award from DARPA was a fixed-price contract with potential total payments to us of $6,794,389 over the course of five years......

......On November 19 Aethlon said will provide Hemopurifier® therapy under FDA expanded access “emergency use” provisions to support requests from qualified physicians and institutes that may seek to treat Ebola virus infection in the United States.

Conclusion: Over the past few weeks AEMD has transformed from unknown and illiquid at a dime to one of the top most traded stocks on the entire OTCBB nearing $0.50 per share. The parabolic move comes on massive investor interest as Aethlon successfully treats a critically-ill Ebola-infected patient with the Aethlon Hemopurifier®.

Positive news continues to flow from the Company as they expand studies for the device in the US under a new FDA Investigational Device Exemption (IDE).

The Ebola virus continues to rage in West Africa with 14,000 reported cases as of November 11 and 5,177 dead in six countries including Liberia, Guinea, Sierra Leone, Nigeria, the United States and Mali.

Currently trading at a $115 million market valuation AEMD has captured the imaginations of small cap investors and is quickly building a loyal shareholder base that swears this one goes higher.

http://www.microcapdaily.com/aethlon-medical-inc-otcmktsaemd-successfully-beating-ebola/16618/